4 ms·

https://www.forbes.com/sites/avikroy/2020/07/24/trumps-most-favored-nation-prescription-drug-executive-order-will-reduce-costs-for-seniors--taxpayers/#322fcecb1

https://www.forbes.com/sites/avikroy/2020/07/24/trumps-most-favored-nation-prescription-drug-executive-order-will-reduce-costs-for-seniors--taxpayers/#322fcecb1860 https://www.forbes.com/sites/avikroy/2020/07/24/trumps-most-... As one might expect, the pharma companies are fighting his executive order in the courts. Here's one article with some details.

doomslice 6y ago
There's also no timeframe for implementation, lacks specific implementation details, and the only teeth it seems to have is that these Federally Qualified Health Centers (FQHCs) may potentially be excluded from grants.